1.Thompson WW, et al. Influenza-associated hospitalizations in the United States. Journal of the American Medical Association 2004; 292: 1333–1340.
2.Collins S. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Reports 1932; 47: 2159–2179.
3.Reichert TA, et al. Influenza and the winter increase in mortality in the United States, 1959–1999. American Journal of Epidemiology 2004; 160: 492–502.
4.Warren-Gash C, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. Journal of Infectious Diseases 2011; 203: 1710–1718.
5.Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infectious Diseases 2010; 10: 83–92.
6.Lamontagne F, et al. Pneumococcal vaccination and risk of myocardial infarction. Canadian Medical Association Journal 2008; 179: 773–777.
7.Madjid M, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. European Heart Journal 2007; 28: 1205–1210.
8.Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infectious Diseases 2009; 9: 601–610.
9.Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518–2532.
10.Macko RF, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996; 27: 2005–2011.
11.Naghavi M, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003; 107: 762–768.
12.Toschke AM, et al. Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age and Ageing 2009; 38: 100–103.
13.Grau AJ, et al. Association of symptoms of chronic bronchitis and frequent flu-like illnesses with stroke. Stroke 2009; 40: 3206–3210.
14.Nichol KL, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine 2003; 348: 1322–1332.
15.Muhammad S, et al. Influenza virus infection aggravates stroke outcome. Stroke 2011; 42: 783–791.
16.Ciszewski A, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. European Heart Journal 2008; 29: 1350–1358.
17.Gwini SM, Coupland CAC, Siriwardena AN. The effect of influenza vaccination on risk of acute myocardial infarction: Self-controlled case-series study. Vaccine 2011; 29: 1145–1149.
18.Grau AJ, et al. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005; 36: 1501–1506.
19.Hung IFN, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clinical Infectious Diseases 2010; 51: 1007–1016.
20.Phrommintikul A, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. European Heart Journal 2011; 32: 1730–1735.
21.Fischer T, et al. Secular trends and seasonality in first-time hospitalization for acute myocardial infarction – a Danish population-based study. International Journal of Cardiology 2004; 97: 425–431.
22.Jensen ES, et al. A 20-year ecological study of the temporal association between influenza and meningococcal disease. European Journal of Epidemiology 2004; 19: 181–187.
23.Katsouyanni K, et al. Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. Journal of Epidemiology and Community Health 1996; 50 Suppl 1: S12–18.
24.Schwartz J, et al. Methodological issues in studies of air pollution and daily counts of deaths or hospital admissions. Journal of Epidemiology and Community Health 1996; 50 (Suppl. 1): S3–11.
25.AHRQ. Nationwide inpatient sample trends supplemental (NIS trends) files. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
26.AHRQ. HCUP NIS database documentation healthcare cost and utilization project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality, 2009.
27.Box GEP, Jenkins GM. Time Series Analysis, Forecasting and Control. San Francsico: Holden-Day, 1976.
28.Cryer JD, Chan K-S. Time Series Analysis with Applications in R, 2nd edn. New York: Springer-Verlag, 2008.
29.Shumway RH, Stoffer DS. Time Series Analysis and its Applications: with R Examples, 3rd edn. New York: Springer, 2011, pp. 1–589.
30.Paganini-Hill A, et al. Infection and risk of ischemic stroke – differences among stroke subtypes. Stroke 2003; 34: 452–457.
31.Choma NN, et al. Non aspirin NSAIDs, cyclo-oxygenase 2 inhibitors and the risk for cardiovascular events: stroke, acute myocardial infarction, and sudden cardiac death. Journal of General Internal Medicine 2008; 23: 351–352.
32.Bavry AA, et al. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. American Journal of Medicine 2011; 124: 614–620.
33.Hayden FG, et al. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clinical Infectious Diseases 2005; 40: 415–422.
34.Engblom E, et al. Fatal influenza – a myocarditis with isolation of virus from the myocardium. Acta Medica Scandinavica 1983; 213: 757–758.
35.Reardon CA, et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology 2001; 21: 1011–1016.
36.Reardon CA, et al. Genetic background selectively influences innominate artery atherosclerosis – immune system deficiency as a probe. Arteriosclerosis Thrombosis and Vascular Biology 2003; 23: 1449– 1454.
37.Bennett BJ, et al. Genetic regulation of atherosclerotic plaque size and morphology in the innominate artery of hyperlipidemic mice. Arteriosclerosis Thrombosis and Vascular Biology 2009; 29: 348–A18.
38.Christoffersen M, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. British Medical Journal 2011; 343: d5497.
39.Marden-Haug N, et al. Code-based syndromic surveillance for influenza like illness by International Classification of Diseases, Ninth Revision. Emerging Infectious Diseases 2007; 13: 207–216.
40.Roumie CL, et al. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiology and Drug Safety 2008; 17: 20–26.
41.Birman-Deych E, et al. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Medical Care 2005; 43: 480–485.